腹膜透析的进展

Progress in peritoneal dialysis (PD).

作者信息

Trevino-Becerra A

机构信息

Dialysis and Renal Transplant Department, Hospital de Especialidades, Centro Medico, La Raza, D.F., Mexico.

出版信息

Biomater Artif Cells Artif Organs. 1987;15(1):183-90. doi: 10.3109/10731198709118518.

DOI:10.3109/10731198709118518

PMID:3449136

Abstract

In the last decade Peritoneal Dialysis treatment has grown specially due to the new technique known as CAPD. However, there are still a lot of problems that need to be solved such as: infection rate, new solutions and improvement of catheters and devices in order to make it safer and to decrease the complications resulted from variants called Peritoneal Dialysis on Alternate Days (PDAD) and Equilibrium Peritoneal Dialysis used in the cases of acute renal failure. Improved PD is suitable to treat the patients in many parts of the world who do not receive any treatment at present.

摘要

在过去十年中，腹膜透析治疗尤其因一种名为持续性非卧床腹膜透析（CAPD）的新技术而得到发展。然而，仍有许多问题需要解决，例如：感染率、新的透析液以及导管和设备的改进，以便使其更安全，并减少因隔日腹膜透析（PDAD）和用于急性肾衰竭病例的平衡腹膜透析等变体导致的并发症。改良的腹膜透析适用于世界上许多目前未接受任何治疗的患者。